Toxicokinetics of 4-methylimidazole in the male F344 rat.
The toxicokinetics and metabolism of 4-methylimidazole (4-MZ) have been studied in the male F344 rat using 14C radiolabelled compound. Radioactivity in plasma and urine was profiled by hplc. After gavage administration of 50 mg/kg, about 85% of the administered radioactivity was recovered in urine within 48 h. The majority of the radioactivity in urine or plasma was associated with the parent compound and only one minor hydrophilic metabolite was present in urine and in plasma. Elimination of radioactivity via fecal, biliary or respiration was negligible. Elimination of 4-MZ after an i.v. dose of 5 mg/kg can be described by a two-compartment process with an estimated half-life of 1.8 h and an estimated apparent volume of distribution of 2.3 litre/kg. After gavage at doses of 5, 50 and 150 mg/kg, 4-MZ was readily absorbed with a estimated bioavailability of 60-70%. Urinary excretion data indicated that renal clearance of 4-MZ accounted for about 80% of total body plasma clearance. Based on the estimated AUC of metabolite and the estimated renal clearance of 4-MZ, the formation of metabolite and the renal clearance of 4-MZ appeared to be a saturable process.
Yuan
J H
JH
National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
Burka
L T
LT
D000284:Administration, Oral; D000818:Animals; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D005919:Glomerular Filtration Rate; D007093:Imidazoles / Q000097:blood / Q000493:pharmacokinetics* / Q000633:toxicity / Q000652:urine; D007275:Injections, Intravenous; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D013431:Sulfates / Q000378:metabolism
D007093:Imidazoles; D013431:Sulfates; C023439:4-methylimidazole